Subacute sclerosing panencephalitis: More cases of this fatal disease are prevented by measles immunization than was previously recognized

Journal of Infectious Diseases

Volumn 192, Issue 10, 2005, Pages 1686-1693

  Bellini, William J ^a   Rota, Jennifer S ^a,d   Lowe, Luis E ^a   Katz, Russell S ^a   Dyken, Paul R ^c   Zaki, Sherif R ^b   Shieh, Wun Ju ^b   Rota, Paul A ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c USA/International SSPE Registry   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE; VIRUS RNA;

ARTICLE; BRAIN TISSUE; CHILD; CLINICAL ARTICLE; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MALE; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SUBACUTE SCLEROSING PANENCEPHALITIS; VACCINATION; VIRUS GENOME; VIRUS INFECTION;

ADOLESCENT; ADULT; BRAIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; POLYMERASE CHAIN REACTION; RNA, VIRAL; SUBACUTE SCLEROSING PANENCEPHALITIS; VACCINATION;

EID: 27744552040     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/497169     Document Type: Article

References (55)

1. Gascon GG. Subacute sclerosing panencephalitis. Semin Pediatr Neurol 1996; 3:260-9.
2. Garg RJ. Subacute sclerosing panencephalitis. Postgrad Med J 2002; 78:63-70.
3. Rima BK. The pathogenesis of subacute sclerosing panencephalitis. Rev Med Virol 1994; 4:81-90.
4. World Health Organization. Update of the nomenclature for describing the genetic characteristics of wild-type measles viruses: new genotypes and reference strains. Wkly Epidemiol Rec 2003; 78:229-32.
5. Rota PA, Bellini WJ. Update on the global distribution of genotypes of wild type measles viruses. J Infect Dis 2003; 187(Suppl 1):S270-6.
6. Jin L, Beard S, Hunjan R, Brown DWG, Miller E. Characterization of measles virus strains causing SSPE: a study of 11 cases. J Neurovirol 2002; 8:335-44.
7. Croxson MC, Anderson NE, Vaughan AA, et al. Subacute measles encephalitis in an immunocompetent adult. J Clin Neurosci 2002; 9:600-4.
8. Rota PA, Bloom AE, Vanchiere JA, Bellini WJ. Evolution of the nucleoprotein and matrix genes of wild-type strains of measles viruses isolated from recent epidemics. Virology 1994; 198:724-30.
9. Forčić D, Baričević M, Zgorelec R, et al. Detection and characterization of measles virus strains in cases of subacute sclerosing panencephalitis in Croatia. Virus Res 2004; 99:51-6.
10. Chung BHY, Ip PPK, Wong VCN, Lo JYC, Harding B. Acute fulminant subacute sclerosing panencephalitis with absent measles and PCR studies in cerebrospinal fluid. Pediatr Neurol 2004; 31:222-4.
11. Ayata M, Kimoto T, Hayashi K, Seto T, Murata R, Ogura H. Nucleotide sequences of the matrix protein gene of subacute sclerosing panencephalitis viruses compared with local contemporary isolates from patients with acute measles. Virus Res 1998; 54:107-15.
12. Miki K, Komase K, Mgone CS, et al. Molecular analysis of measles virus genome derived from SSPE and acute measles patients in Papua, New Guinea. J Med Virol 2002; 68:105-12.
13. Barrero PR, Grippo J, Viegas M, Mistchenko AS. Wild-type measles virus in brain tissue of children with subacute sclerosing panencephalitis, Argentina. Emerg Infect Dis 2003; 9:1333-6.
14. Halsey NA, Modlin JF, Jabbour JT, Dubey L, Eddins DL, Ludwig DD. Risk factors in subacute sclerosing panencephalitis: a case-control study. Am J Epidemiol 1980; 111:415-24.
15. Zilber N, Rannon L, Alter M, Kahana E. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE). Neurology 1983; 33:1558-64.
16. Subacute sclerosing panencephalitis surveillance-United States. MMWR Morb Mortal Wkly Rep 1982; 31:585-8.
17. Modlin JF, Jabbour JT, Witte JJ, Halsey NA. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis. Pediatrics 1977; 59:505-12.
18. Jabbour JT, Duenas DA, Sever JL, Krebs HM, Horta-Barbosa L. Epidemiology of subacute sclerosing panencephalitis (SSPE): a report of the SSPE registry. JAMA 1972; 220:959-62.
19. Dyken PR. Neuroprogressive disease of post-infectious origin: a review of a resurging subacute sclerosing panencephalitis (SSPE). Ment Retard Dev Disabil Res Rev 2001; 7:217-25.
20. Gindler JS, Atkinson WL, Markowitz LE, Hutchins SS. Epidemiology of measles in the United States in 1989 and 1990. Pediatr Infect Dis J 1992; 11:841-6.
21. Orenstein WA, Papania MJ, Wharton ME. Measles elimination in the United States. J Infect Dis 2004; 189(Suppl 1):S1-3.
22. Hinman AR, Orenstein WA, Papania MJ. Evolution of measles elimination strategies in the United States. J Infect Dis 2004; 189(Suppl 1):S17-22.
23. Rota PA, Rota JS, Redd SB, Papania MJ, Bellini WJ. Genetic analysis of measles viruses isolated in the United States between 1989 and 2001: absence of an endemic genotype since 1994. J Infect Dis 2004; 189(Suppl l):S160-4.
24. Katz SL, Hinman AR. Summary and conclusions: measles elimination meeting, 16-17 March 2000. J Infect Dis 2004;189(Suppl 1):S43-7.
25. Zaki SR, Bellini WJ. Measles. In: Connor DH, Chandler FW, Schwartz DA, Manz HJ, Lack EE, eds. Pathology of infectious diseases. Stamford, CT: Appleton & Lange, 1997:233-44.
26. Koopmans M, Monroe SS, Coffield LM, Zaki SR. Optimization of extraction and PCR amplification of RNA extracts from paraffin-embedded tissue in different fixatives. J Virol Methods 1993; 43:189-204.
27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-69.
28. Katz RS, Premenko-Lanier M, McChesney MB, Rota PA, Bellini WJ. Detection of measles virus RNA in whole blood stored on filter paper. J Med Virol 2002; 67:596-602.
29. Devereaux J, Haeberli P, Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res 1984; 12:387-95.
30. Swofford DL. PAUP: phylogenetic analysis using parsimony. Version 3.1.1. Champaign, IL: Illinois Natural History Survey, 1991.
31. Dlugos DJ, Brooks-Kayal AR. A 4-year-old with pica, progressive in-coordination, and decreased responsiveness. Semin Pediatr Neurol 1999; 6:164-7.
32. Park SY, Kohl S. Subacute sclerosing panencephalitis in an identical twin. Pediatrics 1999; 104:1390-4.
33. Honarmand S, Glaser CA, Chow E, et al. Subacute sclerosing panencephalitis in the differential diagnosis of encephalitis. Neurology 2004; 63:1489-93.
34. Baram TZ, Gonzalez-Gomez I, Xie Z-D, et al. Subacute sclerosing panencephalitis in an infant: diagnostic role of viral genome analysis. Ann Neurol 1994; 36:103-8.
35. PeBenito R, Naqvi SH, Area MM, Schubert R. Fulminating subacute sclerosing panencephalitis: case report and literature review. Clin Pediatr (Phila) 1997; 36:149-54.
36. Koppel BS, Poon TP, Khandji A, Pavlakis SG, Pedley TA. Subacute sclerosing panencephalitis and acquired immunodeficiency syndrome: role of electroencephalography and magnetic resonance imaging. J Neuroimaging 1996; 6(2):122-5.
37. Nakayama T, Fujino M, Yoshida N. Molecular epidemiology of measles virus in Japan. Pediatr Int 2004; 46:214-23.
38. Rima BK, Earle JAP, Yeo RP, et al. Temporal and geographical distribution of measles virus genotypes. J Gen Virol 1995; 76:1173-80.
39. Tipples GA, Gray M, Garbutt M, Rota PA, the Canadian Measles Surveillance Program. Genotyping of measles virus in Canada: 1979-2002. J Infect Dis 2004; 189(Suppl 1):S171-6.
40. Hutchins S, Markowitz L, Atkinson W, Swint E, Hadler S. Measles outbreaks in the United States, 1987 through 1990. Pediatr Infect Dis J 1996; 15:31-8.
41. Atkinson WL, Hadler SC, Redd SB, Orenstein WA. Measles surveillance-United States, 1991. MMWR CDC Surveill Summ 1992; 41(6):1-12.
42. Miller C, Farrington CP, Harbert K. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. Int J Epidemiol 1992; 21:998-1006.
43. Yalaz K, Anlar B, Renda Y, Aysun S, Topcu M, Ozdirim E. Subacute sclerosing panencephalitis in Turkey: epidemiologic features. J Trop Pediatr 1988; 34:301-5.
44. Saha V, John TJ, Mukundan P, et al. High incidence of subacute sclerosing panencephalitis in South India. Epidemiol Infect 1990; 104:151-6.
45. Miller C, Andrews N, Rush M, Munro H, Jin L, Miller E. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002. Arch Dis Child 2004; 89:1145-8.
46. Harpaz R. Completeness of measles cases reporting: review of estimates for the United States. J Infect Dis 2004; 189(Suppl 1):S185-90.
47. Ewert DP, Frederick PD, Run GHF, Mascola L. The reporting efficiency of measles by hospitals in Los Angeles County, 1986 and 1989. Am J Public Health 1994; 84:868-9.
48. Ewert DP, Westman S, Frederick PD, Waterman SH. Measles reporting completeness during a community-wide epidemic in inner-city Los Angeles. Public Health Rep 1995; 110:161-5.
49. Miller C, Farrington CP, Harbert K. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. Int J Epidemiol 1992; 21:998-1006.
50. Centers for Disease Control and Prevention (CDC). Measles surveillance report no. 10 1973-1976. Atlanta: CDC, July 1977.
51. Jabbour JT, Duenas DA, Sever JL, Krebs HM, Horta-Barbosa L. Epidemiology of subacute sclerosing panencephalitis (SSPE): a report of the SSPE registry. JAMA 1972; 220:959-62.
52. Frings M, Blaeser I, Kastrup O. Adult-onset subacute sclerosing panencephalitis presenting as a degenerative dementia syndrome. J Neurol 2002; 249:942-3.
53. Singer C, Lang AE, Suchowersky O. Adult-onset subacute sclerosing panencephalitis: case reports and review of the literature. Mov Disord 1997; 12:342-53.
54. Centers for Disease Control and Prevention. Measles-United States, 1990. MMWR Morb Mortal Wkly Rep 1991; 40(22):369-72.
55. Takasu T, Mgone JM, Mgone CS, et al. A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea. Epidemiol Infect 2003; 131:887-98.